Cyclooxygenase-2 (COX-2) inhibitors in breast cancer therapy
A detailed description of cyclooxygenase-2 (COX-2) inhibitors
(celecoxib, apricoxib) that are currently used in routine therapy or
are in clinical trials in breast cancer patients.
In « Molecular Therapy of Breast Cancer: Classicism Meets Modernity ».
by Marc Lacroix
InTextoResearch, Baelen (Liège, Wallonia), Belgium
Nova Sciences Publishers, New York, ISBN 978-1-60741-593-0